跳至主要内容
临床试验/NCT03827499
NCT03827499已完成不适用

Effects of β-hydroxy-β-methylbutyrate (HMB) Supplementation in Addition to Multicomponent Exercise in Old Adults Living in Nursing Homes

Universidad de Murcia2 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2019年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
104
试验地点
2
主要终点
Change in physical functional performance based on the Short Physical Performance Battery (SPPB) score

研究概览

简要总结

Evidence supports the fact that multicomponent exercise and β-hydroxy-β-methylbutyrate (HMB) supplementation are, separately, effective in improving old adult's health and palliate functional metabolic diseases in the elderly. However, the true effect of HMB supplementation combined with a tailored exercise program in frail old adults is still unknown. Thus, the aim of the HEAL study is to assess the effects of the combination of a daily multicomponent exercise and resistance training intervention in addition to HMB supplementation on old adults' health.

详细描述

Evidence supports the fact that multicomponent exercise and β-hydroxy-β-methylbutyrate (HMB) supplementation are, separately, effective in improving old adult's health and palliate functional metabolic diseases in the elderly. However, the true effect of HMB supplementation combined with a tailored exercise program in frail old adults is still unknown.

Thus, the aim of the HEAL study is to assess the effects of the combination of a daily multicomponent exercise and resistance training intervention in addition to HMB supplementation on old adults' health.

The findings of the HEAL study will help professionals from public health systems to identify cost-effectiveness and innovative actions to improve older people's health and quality of life, and endorse exercise practice in older adults living in nursing homes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women aged ≥70 years living in a nursing home
  • Be able to follow an active physical rehabilitation program
  • Be able to read and wright
  • Voluntary participation
  • Capable and willing to provide an informed consent

排除标准

  • Acute heart attack (recent 3-6 months) or unstable angina
  • Uncontrolled atrial or ventricular arrhythmias
  • Aortic dissecting aneurysm
  • Severe aortic stenosis
  • Acute endocarditis / pericarditis
  • Uncontrolled high blood pressure (>180/100 mmHg)
  • Acute thromboembolism
  • Acute or severe heart failure
  • Acute or severe respiratory failure
  • Uncontrolled postural hypotension
  • Uncontrolled acute decompensated diabetes mellitus or low blood sugar
  • A recent fracture in the last month.
  • Coincident participation in any intervention trial
  • HMB contraindication, intolerance, or allergy
  • Community-dwelling people
  • Have regularly performed exercise (>20 minutes >3 days/week) in the last 3 months
  • Malignant diseases (exceptions: basal or squamous-cell skin carcinoma or carcinoma in situ of the uterine cervix)
  • Revascularization within 1 year
  • Severe loss of vision, hearing, or communicative ability
  • Conditions preventing cooperation

结局指标

主要结局

Change in physical functional performance based on the Short Physical Performance Battery (SPPB) score

时间窗: Baseline to 25 Weeks

Summary scores range from 0-12 and higher scores denote higher physical performance.

次要结局

  • Change in upper-body strength (kg)(Baseline to 25 Weeks)
  • Change in Handgrip strength (kg)(Baseline to 25 Weeks)
  • Change in glycaemic profile(Baseline to Week 25)
  • Change in Comorbidity (score)(Baseline to 25 Weeks)
  • Change in cognitive function (score)(Baseline to 25 Weeks)
  • Change in lower-body strength (kg)(Baseline to 25 Weeks)
  • Change in upper-body strength power output (m/s)(Baseline to 25 Weeks)
  • Change in frailty (score)(Baseline to 25 Weeks)
  • Change in Disability (Lawton index scores)(Baseline to 25 Weeks)
  • Change in lipid profile(Baseline to Week 25)
  • Change in Thyroid-Stimulating Hormone (mIU/L)(Baseline to Week 25)
  • Change in lower-body strength power output (m/s)(Baseline to 25 Weeks)
  • Change in lean body mass (kg)(Baseline to Week 25)
  • Change in Disability (Barthel index scores)(Baseline to 25 Weeks)
  • Change in depression (score)(Baseline to 25 Weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Javier Courel Ibáñez

Ph.D

Universidad de Murcia

研究点 (2)

Loading locations...

相似试验

HMB Supplementation in Addition to Multicomponent... | 临床试验